Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide.
about
Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophages.Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disordersVPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.The multiple faces of prostaglandin E2 G-protein coupled receptor signaling during the dendritic cell life cycle.Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.Disease-Associated Plasmacytoid Dendritic Cells.Toll-like receptor stimulation differentially regulates vasoactive intestinal peptide type 2 receptor in macrophagesExcessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-α responses by pDC
P2860
Q30496008-8193B8AF-3EEF-4C18-90FF-2C3E767919AFQ34025143-2E02930E-F558-4EED-9D9C-44C8F653297AQ35893267-B36FE9E5-0732-454F-AD8B-802E96A3A468Q36830470-12155835-388E-469D-A05F-E2DEF173A6C3Q37054934-FBF9B7DD-B5AE-4283-BAAE-0068AD0B1D5FQ38093015-6037B80E-06CD-428D-B3FC-11186374FC2DQ39551385-1DE438BE-6344-4FCF-9E72-53995E037B02Q39860663-B5AF631D-59C4-4AB8-B292-F8C30A940256Q43930865-9E042A08-1F81-4593-9741-E11C61C1D594Q57235467-D2F22ACD-4D01-49D6-B627-C7E6E3795FB8Q57339899-3AEF5F74-0D59-4DC1-9880-75840554ADDB
P2860
Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@en
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@nl
type
label
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@en
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@nl
prefLabel
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@en
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@nl
P2093
P1476
Human plasmacytoid dendritic c ...... vasoactive intestinal peptide.
@en
P2093
Bernd Jahrsdörfer
Dorit Fabricius
M Sue O'Dorisio
Sue Blackwell
P304
P356
10.4049/JIMMUNOL.177.9.5920
P407
P577
2006-11-01T00:00:00Z